Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | -20.62% | -21.82% | -62.47% |
Jun. 07 | Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target | MT |
May. 30 | SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer | CI |